Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CTH | P32929 | 1/20 | 0.32 |
| ▸ | CBS | P35520 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | PAM | P19021 | 2/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL28785631 | 0.84 | — | — | |
| Malonic Acid SCHEMBL5779578 | 0.82 | LDHA (0.43) | TSHRFFAR3ALDH1A1HCAR2 | |
| Acetic Acid SCHEMBL6676468 | 0.81 | — | — | |
| Glycine SCHEMBL27759657 | 0.80 | GLRA1 (0.46) | TSHRFFAR3ALDH1A1HCAR2 | |
| Acrylic Acid SCHEMBL28659504 | 0.79 | LMNA (0.50) | TSHRFFAR3ALDH1A1HCAR2 | |
| Propene SCHEMBL28007385 | 0.79 | PTGS1 (0.44) | PTGS1TSHRCTHCBSTHPO | |
| Maleic Acid SCHEMBL5854822 | 0.77 | HCAR2 (0.52) | L3MBTL1TSHRALDH1A1HCAR2 | |
| Fumaric Acid SCHEMBL718708 | 0.77 | HCAR2 (0.52) | L3MBTL1TSHRALDH1A1HCAR2 | |
| Propene SCHEMBL28818285 | 0.77 | PTGS1 (0.40) | PTGS1GLAL3MBTL1TSHRCTH | |
| Fumaric Acid SCHEMBL28225492 | 0.77 | HCAR2 (0.52) | L3MBTL1TSHRALDH1A1HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4171395-A2 | COMPRESSIBLE ADJUNCTS WITH DRUG DOSAGE CONTROL FEATURES | Cilag GmbH International (CH) | 2023-05-03 | — | — | EP | disclosed |
| EP-4161405-A1 | COMPRESSIBLE ADJUNCTS WITH DRUG RELEASE FEATURES | Cilag GmbH International (CH) | 2023-04-12 | — | — | EP | disclosed |
| EP-4146089-A2 | COMPRESSIBLE ADJUNCTS DIFFERENT BEHAVIORAL ZONES | Cilag GmbH International (CH) | 2023-03-15 | — | — | EP | disclosed |
| EP-4146091-A2 | COMPRESSIBLE ADJUNCTS WITH FLUID CONTROL FEATURES | Cilag GmbH International (CH) | 2023-03-15 | — | — | EP | disclosed |
| EP-4146090-A1 | COMPRESSIBLE ADJUNCTS WITH DRUG RELEASE FEATURES | Cilag GmbH International (CH) | 2023-03-15 | — | — | EP | disclosed |
| EP-4135597-A1 | COMPRESSIBLE ADJUNCTS WITH HEALING-DEPENDENT DEGRADATION PROFILE | Cilag GmbH International (CH) | 2023-02-22 | — | — | EP | disclosed |
| EP-4132379-A1 | TISSUE THICKNESS COMPENSATING ADJUNCTS HAVING REGIONS OF DIFFERENTIAL EXPANSION | Cilag GmbH International (CH) | 2023-02-15 | — | — | EP | disclosed |
| EP-4132381-A1 | IMPLANTABLE ADJUNCTS HAVING ADJUSTABLE DEGRADATION PROFILE | Cilag GmbH International (CH) | 2023-02-15 | — | — | EP | disclosed |
| EP-4132380-A1 | COMPOSITE ADJUNCTS THAT DEGRADE THROUGH MULTIPLE DIFFERENT MECHANISMS | Cilag GmbH International (CH) | 2023-02-15 | — | — | EP | disclosed |
| WO-2022208277-A2 | COMPRESSIBLE ADJUNCTS WITH DRUG DOSAGE CONTROL FEATURES | CILAG GMBH INTERNATIONAL (CH) | 2022-10-06 | — | — | WO | disclosed |
| WO-2022208299-A1 | COMPRESSIBLE ADJUNCTS WITH DRUG RELEASE FEATURES | CILAG GMBH INTERNATIONAL (CH) | 2022-10-06 | — | — | WO | disclosed |
| WO-2022208292-A1 | COMPOSITE ADJUNCTS THAT DEGRADE THROUGH MULTIPLE DIFFERENT MECHANISMS | CILAG GMBH INTERNATIONAL (CH) | 2022-10-06 | — | — | WO | disclosed |
| WO-2022208276-A2 | COMPRESSIBLE ADJUNCTS DIFFERENT BEHAVIORAL ZONES | CILAG GMBH INTERNATIONAL (CH) | 2022-10-06 | — | — | WO | disclosed |
| WO-2022208279-A1 | COMPRESSIBLE ADJUNCTS WITH DRUG RELEASE FEATURES | CILAG GMBH INTERNATIONAL (CH) | 2022-10-06 | — | — | WO | disclosed |
| WO-2022208297-A1 | IMPLANTABLE ADJUNCTS HAVING ADJUSTABLE DEGRADATION PROFILE | CILAG GMBH INTERNATIONAL (CH) | 2022-10-06 | — | — | WO | disclosed |
| WO-2022208302-A2 | COMPRESSIBLE ADJUNCTS WITH FLUID CONTROL FEATURES | CILAG GMBH INTERNATIONAL (CH) | 2022-10-06 | — | — | WO | disclosed |
| WO-2022208296-A1 | COMPRESSIBLE ADJUNCTS WITH HEALING-DEPENDENT DEGRADATION PROFILE | CILAG GMBH INTERNATIONAL (CH) | 2022-10-06 | — | — | WO | disclosed |
| WO-2022208285-A1 | TISSUE THICKNESS COMPENSATING ADJUNCTS HAVING REGIONS OF DIFFERENTIAL EXPANSION | CILAG GMBH INTERNATIONAL (CH) | 2022-10-06 | — | — | WO | disclosed |